GLP-1 Drugs Tied to Lower Risk of Legal Blindness in People With Diabetes
Medpage Today, Oct. 21, 2025
Medpage reports on a UTMB retrospective cohort study that linked GLP-1 receptor agonists to a lower risk of legal blindness in patients with type 2 diabetes and risk for cardiovascular disease. UTMB’s Dr. Praveena Gupta, Dr. Andrew G. Lee and UTMB medical student Ethan Jarrett, all authors on the study, were quoted in the Medpage article.